Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Phosphoproteins | 20 | 2017 | 163 | 3.580 |
Why?
|
Ribosomal Protein S6 Kinases, 90-kDa | 7 | 2017 | 22 | 2.710 |
Why?
|
Intracellular Signaling Peptides and Proteins | 13 | 2017 | 187 | 1.820 |
Why?
|
Cell Movement | 9 | 2017 | 571 | 1.750 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 8 | 2012 | 93 | 1.410 |
Why?
|
Cell Adhesion | 11 | 2016 | 212 | 1.350 |
Why?
|
Integrins | 9 | 2017 | 51 | 1.150 |
Why?
|
Signal Transduction | 16 | 2017 | 1908 | 1.040 |
Why?
|
Apoptosis Regulatory Proteins | 17 | 2017 | 147 | 0.900 |
Why?
|
Brain Neoplasms | 2 | 2016 | 111 | 0.800 |
Why?
|
Cloning, Molecular | 5 | 2006 | 325 | 0.690 |
Why?
|
Phosphorylation | 10 | 2017 | 928 | 0.660 |
Why?
|
Animals | 38 | 2017 | 15081 | 0.630 |
Why?
|
rho GTP-Binding Proteins | 1 | 2017 | 22 | 0.620 |
Why?
|
Neoplasms | 4 | 2013 | 1103 | 0.610 |
Why?
|
Serine | 1 | 2017 | 75 | 0.610 |
Why?
|
Sesquiterpenes, Guaiane | 2 | 2016 | 3 | 0.580 |
Why?
|
MAP Kinase Signaling System | 6 | 2012 | 169 | 0.570 |
Why?
|
Glioblastoma | 2 | 2016 | 55 | 0.560 |
Why?
|
ras Proteins | 4 | 2012 | 51 | 0.540 |
Why?
|
Enzyme Activation | 7 | 2017 | 444 | 0.500 |
Why?
|
Antineoplastic Agents | 4 | 2016 | 803 | 0.480 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2014 | 172 | 0.470 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2011 | 48 | 0.440 |
Why?
|
Phospholipase D | 2 | 2011 | 49 | 0.440 |
Why?
|
Necrosis | 1 | 2012 | 49 | 0.430 |
Why?
|
CHO Cells | 10 | 2012 | 124 | 0.420 |
Why?
|
Protein Binding | 10 | 2012 | 972 | 0.410 |
Why?
|
Cricetinae | 10 | 2012 | 238 | 0.410 |
Why?
|
Apoptosis | 8 | 2015 | 1398 | 0.400 |
Why?
|
Neuroblastoma | 1 | 2012 | 129 | 0.380 |
Why?
|
COS Cells | 6 | 2012 | 69 | 0.380 |
Why?
|
Cell Line, Tumor | 7 | 2017 | 2231 | 0.370 |
Why?
|
Humans | 31 | 2017 | 37093 | 0.370 |
Why?
|
Carboxylic Ester Hydrolases | 3 | 2017 | 52 | 0.360 |
Why?
|
Fibronectins | 5 | 2011 | 66 | 0.360 |
Why?
|
Cell Proliferation | 9 | 2017 | 1198 | 0.350 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2010 | 55 | 0.350 |
Why?
|
Spatial Behavior | 1 | 2009 | 22 | 0.350 |
Why?
|
Mice | 14 | 2017 | 5913 | 0.350 |
Why?
|
Flow Cytometry | 4 | 2006 | 399 | 0.350 |
Why?
|
Exploratory Behavior | 1 | 2009 | 75 | 0.340 |
Why?
|
Maze Learning | 1 | 2009 | 105 | 0.340 |
Why?
|
Mitogen-Activated Protein Kinases | 5 | 2003 | 136 | 0.340 |
Why?
|
Death Domain Receptor Signaling Adaptor Proteins | 1 | 2009 | 3 | 0.340 |
Why?
|
Gastrula | 4 | 1996 | 6 | 0.320 |
Why?
|
Cells | 1 | 2008 | 9 | 0.320 |
Why?
|
Mice, Knockout | 7 | 2017 | 933 | 0.310 |
Why?
|
Molecular Biology | 1 | 2008 | 46 | 0.300 |
Why?
|
Glioma | 1 | 2008 | 79 | 0.290 |
Why?
|
Hela Cells | 4 | 2012 | 366 | 0.280 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2008 | 182 | 0.270 |
Why?
|
Cell Adhesion Molecules | 2 | 2006 | 75 | 0.260 |
Why?
|
Neoplasm Invasiveness | 3 | 2016 | 251 | 0.260 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2005 | 190 | 0.230 |
Why?
|
Cell Survival | 6 | 2012 | 864 | 0.230 |
Why?
|
Myocytes, Smooth Muscle | 2 | 2017 | 86 | 0.230 |
Why?
|
Mitochondrial Proteins | 2 | 2017 | 107 | 0.230 |
Why?
|
Neoplasm Metastasis | 3 | 2013 | 219 | 0.220 |
Why?
|
Up-Regulation | 1 | 2006 | 513 | 0.220 |
Why?
|
Cytoplasm | 3 | 2012 | 143 | 0.220 |
Why?
|
Anxiety | 1 | 2009 | 754 | 0.210 |
Why?
|
Transfection | 7 | 2015 | 523 | 0.200 |
Why?
|
Contractile Proteins | 2 | 2012 | 8 | 0.200 |
Why?
|
Cricetulus | 3 | 2012 | 80 | 0.200 |
Why?
|
Microfilament Proteins | 2 | 2012 | 69 | 0.200 |
Why?
|
Cell Line | 5 | 2015 | 1354 | 0.190 |
Why?
|
MAP Kinase Kinase Kinase 1 | 1 | 2000 | 2 | 0.190 |
Why?
|
Xenopus laevis | 3 | 1996 | 73 | 0.180 |
Why?
|
Embryonic Induction | 2 | 1996 | 3 | 0.180 |
Why?
|
Molecular Sequence Data | 8 | 2005 | 1568 | 0.180 |
Why?
|
Models, Molecular | 4 | 2012 | 808 | 0.170 |
Why?
|
Amino Acid Sequence | 7 | 2005 | 1180 | 0.170 |
Why?
|
Muscle Development | 2 | 2017 | 45 | 0.160 |
Why?
|
Threonine | 1 | 2017 | 25 | 0.160 |
Why?
|
Carotid Artery Injuries | 1 | 2017 | 4 | 0.150 |
Why?
|
Molecular Structure | 3 | 2016 | 492 | 0.150 |
Why?
|
Muscular Dystrophy, Duchenne | 1 | 2017 | 10 | 0.150 |
Why?
|
Mutation | 4 | 2017 | 1095 | 0.150 |
Why?
|
Gene Expression Regulation | 3 | 2011 | 1015 | 0.140 |
Why?
|
Receptors, Somatostatin | 1 | 2016 | 5 | 0.140 |
Why?
|
Active Transport, Cell Nucleus | 4 | 2011 | 59 | 0.140 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 1996 | 2 | 0.140 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 4 | 2017 | 99 | 0.140 |
Why?
|
RNA Interference | 1 | 2017 | 243 | 0.140 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2017 | 130 | 0.140 |
Why?
|
Receptors, Opioid, mu | 1 | 2016 | 55 | 0.140 |
Why?
|
Substrate Specificity | 2 | 2007 | 212 | 0.140 |
Why?
|
Diamines | 1 | 2015 | 7 | 0.130 |
Why?
|
Polycyclic Compounds | 1 | 2015 | 7 | 0.130 |
Why?
|
Porifera | 1 | 2015 | 8 | 0.130 |
Why?
|
Sequence Homology, Amino Acid | 4 | 2005 | 269 | 0.120 |
Why?
|
Ruthenium | 1 | 2014 | 15 | 0.120 |
Why?
|
Muscle, Skeletal | 1 | 2017 | 282 | 0.120 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2016 | 1039 | 0.120 |
Why?
|
Coordination Complexes | 1 | 2014 | 28 | 0.120 |
Why?
|
Alkaloids | 1 | 2015 | 39 | 0.120 |
Why?
|
Organometallic Compounds | 1 | 2014 | 73 | 0.120 |
Why?
|
Morphogenesis | 2 | 2009 | 50 | 0.120 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2014 | 29 | 0.120 |
Why?
|
Mice, Inbred C57BL | 3 | 2017 | 1609 | 0.110 |
Why?
|
Gene Deletion | 1 | 2014 | 166 | 0.110 |
Why?
|
raf Kinases | 1 | 2012 | 7 | 0.110 |
Why?
|
Isoenzymes | 1 | 2013 | 161 | 0.110 |
Why?
|
Talin | 1 | 2012 | 3 | 0.110 |
Why?
|
DNA Primers | 3 | 2010 | 286 | 0.110 |
Why?
|
Staurosporine | 1 | 2012 | 38 | 0.110 |
Why?
|
Chloroquine | 1 | 2012 | 19 | 0.110 |
Why?
|
Skin | 1 | 2014 | 174 | 0.110 |
Why?
|
Gene Amplification | 1 | 2012 | 26 | 0.100 |
Why?
|
Oncogene Proteins | 1 | 2012 | 21 | 0.100 |
Why?
|
Cells, Cultured | 3 | 2017 | 1518 | 0.100 |
Why?
|
Recombinant Fusion Proteins | 4 | 2003 | 295 | 0.100 |
Why?
|
Skin Neoplasms | 1 | 2014 | 159 | 0.100 |
Why?
|
Kidney Neoplasms | 1 | 2012 | 68 | 0.100 |
Why?
|
Gene Library | 2 | 2002 | 57 | 0.100 |
Why?
|
Oligopeptides | 3 | 1996 | 102 | 0.100 |
Why?
|
Cell Differentiation | 1 | 2015 | 587 | 0.100 |
Why?
|
Chromosome Aberrations | 1 | 2012 | 60 | 0.100 |
Why?
|
Autophagy | 1 | 2012 | 116 | 0.100 |
Why?
|
Protein Conformation | 2 | 2011 | 389 | 0.100 |
Why?
|
RNA, Messenger | 2 | 2012 | 1207 | 0.100 |
Why?
|
Base Sequence | 3 | 2010 | 997 | 0.100 |
Why?
|
Phospholipase C gamma | 1 | 2011 | 8 | 0.100 |
Why?
|
Protease Inhibitors | 1 | 2011 | 49 | 0.100 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 2014 | 41 | 0.100 |
Why?
|
Models, Biological | 3 | 2015 | 677 | 0.100 |
Why?
|
Mice, Nude | 1 | 2011 | 337 | 0.090 |
Why?
|
Amino Acids | 1 | 2011 | 145 | 0.090 |
Why?
|
Jurkat Cells | 1 | 2010 | 79 | 0.090 |
Why?
|
Reactive Oxygen Species | 1 | 2012 | 461 | 0.090 |
Why?
|
Discrimination Learning | 1 | 2009 | 28 | 0.090 |
Why?
|
Pain Threshold | 1 | 2009 | 28 | 0.090 |
Why?
|
Nuclear Proteins | 1 | 2012 | 307 | 0.090 |
Why?
|
Association Learning | 1 | 2009 | 30 | 0.090 |
Why?
|
Interleukin-2 | 1 | 2010 | 89 | 0.090 |
Why?
|
Calcium | 1 | 2012 | 480 | 0.090 |
Why?
|
Enzyme Inhibitors | 1 | 2011 | 433 | 0.090 |
Why?
|
Hand Strength | 1 | 2009 | 34 | 0.090 |
Why?
|
Prognosis | 1 | 2012 | 739 | 0.080 |
Why?
|
Avoidance Learning | 1 | 2009 | 62 | 0.080 |
Why?
|
Kidney | 1 | 2011 | 337 | 0.080 |
Why?
|
Melanoma | 1 | 2010 | 96 | 0.080 |
Why?
|
Cell Nucleus | 3 | 2006 | 366 | 0.080 |
Why?
|
Pain Measurement | 1 | 2009 | 171 | 0.080 |
Why?
|
Protein Isoforms | 1 | 2009 | 130 | 0.080 |
Why?
|
Peptides | 1 | 2011 | 320 | 0.080 |
Why?
|
Analysis of Variance | 1 | 2009 | 550 | 0.080 |
Why?
|
DNA, Complementary | 3 | 2003 | 191 | 0.080 |
Why?
|
Behavior, Animal | 1 | 2009 | 314 | 0.070 |
Why?
|
T-Lymphocytes | 1 | 2010 | 357 | 0.070 |
Why?
|
Protein Kinase C-delta | 1 | 2006 | 18 | 0.070 |
Why?
|
Fear | 1 | 2009 | 249 | 0.070 |
Why?
|
Activins | 2 | 1996 | 7 | 0.070 |
Why?
|
Motor Activity | 1 | 2009 | 418 | 0.070 |
Why?
|
Cell Division | 2 | 2005 | 307 | 0.070 |
Why?
|
Inhibins | 2 | 1996 | 5 | 0.070 |
Why?
|
Structure-Activity Relationship | 3 | 2016 | 409 | 0.070 |
Why?
|
Binding Sites | 5 | 2002 | 651 | 0.070 |
Why?
|
Hyperplasia | 2 | 2017 | 38 | 0.070 |
Why?
|
Fas-Associated Death Domain Protein | 1 | 2005 | 3 | 0.070 |
Why?
|
Muscle Fibers, Skeletal | 2 | 2017 | 64 | 0.070 |
Why?
|
Drug Screening Assays, Antitumor | 2 | 2016 | 113 | 0.060 |
Why?
|
Cell Separation | 2 | 2003 | 93 | 0.060 |
Why?
|
Extracellular Matrix | 1 | 2006 | 115 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 3 | 2017 | 103 | 0.060 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2017 | 286 | 0.060 |
Why?
|
Ubiquitin | 1 | 2005 | 78 | 0.060 |
Why?
|
Protein Transport | 1 | 2005 | 302 | 0.060 |
Why?
|
Precipitin Tests | 3 | 2001 | 52 | 0.060 |
Why?
|
3T3 Cells | 2 | 2001 | 59 | 0.060 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2003 | 95 | 0.060 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2006 | 40 | 0.060 |
Why?
|
Antibodies, Monoclonal | 3 | 2001 | 290 | 0.060 |
Why?
|
Astrocytes | 1 | 2006 | 255 | 0.060 |
Why?
|
Down-Regulation | 1 | 2005 | 435 | 0.050 |
Why?
|
Fluorescent Antibody Technique | 1 | 2003 | 189 | 0.050 |
Why?
|
Caspase 3 | 2 | 2015 | 207 | 0.050 |
Why?
|
Sequence Alignment | 2 | 2002 | 265 | 0.050 |
Why?
|
Gene Expression Profiling | 1 | 2006 | 626 | 0.050 |
Why?
|
Transformation, Genetic | 1 | 2001 | 21 | 0.050 |
Why?
|
Histones | 1 | 2003 | 190 | 0.050 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2002 | 112 | 0.050 |
Why?
|
Time Factors | 4 | 2017 | 1742 | 0.050 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 2 | 2003 | 201 | 0.050 |
Why?
|
Green Fluorescent Proteins | 3 | 2011 | 208 | 0.050 |
Why?
|
Adult | 1 | 2016 | 11712 | 0.050 |
Why?
|
RNA, Small Interfering | 2 | 2015 | 409 | 0.050 |
Why?
|
Guanosine Triphosphate | 1 | 2000 | 18 | 0.050 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2000 | 77 | 0.050 |
Why?
|
Sensitivity and Specificity | 1 | 2001 | 562 | 0.040 |
Why?
|
Protein Structure, Tertiary | 4 | 2003 | 408 | 0.040 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2000 | 168 | 0.040 |
Why?
|
Microscopy, Fluorescence | 3 | 2010 | 252 | 0.040 |
Why?
|
Mesoderm | 2 | 1996 | 70 | 0.040 |
Why?
|
Cell Membrane | 2 | 2003 | 381 | 0.040 |
Why?
|
Tissue Culture Techniques | 1 | 2017 | 32 | 0.040 |
Why?
|
Carotid Arteries | 1 | 2017 | 28 | 0.040 |
Why?
|
Saphenous Vein | 1 | 2017 | 23 | 0.040 |
Why?
|
Sarcolemma | 1 | 2017 | 3 | 0.040 |
Why?
|
Mice, Inbred mdx | 1 | 2017 | 5 | 0.040 |
Why?
|
Dystrophin | 1 | 2017 | 19 | 0.040 |
Why?
|
Antigens, CD | 1 | 1997 | 121 | 0.040 |
Why?
|
Integrin alpha4beta1 | 1 | 1996 | 5 | 0.040 |
Why?
|
Pleurodeles | 1 | 1996 | 1 | 0.040 |
Why?
|
Heparin | 1 | 1996 | 35 | 0.030 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2016 | 34 | 0.030 |
Why?
|
Biological Availability | 1 | 2016 | 88 | 0.030 |
Why?
|
Plasmids | 2 | 2011 | 246 | 0.030 |
Why?
|
Administration, Oral | 1 | 2016 | 224 | 0.030 |
Why?
|
Carrier Proteins | 1 | 1997 | 305 | 0.030 |
Why?
|
Indonesia | 1 | 2015 | 12 | 0.030 |
Why?
|
Myoblasts | 1 | 2015 | 27 | 0.030 |
Why?
|
Phosphoranes | 1 | 2014 | 3 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2014 | 45 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2016 | 111 | 0.030 |
Why?
|
Phenotype | 1 | 2017 | 689 | 0.030 |
Why?
|
Solubility | 1 | 2014 | 118 | 0.030 |
Why?
|
Nuclear Magnetic Resonance, Biomolecular | 1 | 2015 | 84 | 0.030 |
Why?
|
Mice, SCID | 1 | 2014 | 150 | 0.030 |
Why?
|
Rats | 2 | 2016 | 3483 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2015 | 173 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 152 | 0.030 |
Why?
|
Genes, ras | 1 | 2014 | 25 | 0.030 |
Why?
|
Codon | 1 | 2014 | 42 | 0.030 |
Why?
|
Gene Targeting | 1 | 2014 | 38 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2011 | 578 | 0.030 |
Why?
|
Blotting, Western | 2 | 2010 | 859 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2017 | 628 | 0.030 |
Why?
|
Transcriptional Activation | 1 | 2014 | 172 | 0.030 |
Why?
|
Amino Acid Motifs | 2 | 2003 | 91 | 0.030 |
Why?
|
Luminescent Proteins | 2 | 2003 | 77 | 0.030 |
Why?
|
Water | 1 | 2014 | 296 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2017 | 1371 | 0.030 |
Why?
|
Matrix Metalloproteinase 12 | 1 | 2011 | 4 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2011 | 8 | 0.020 |
Why?
|
Culture Media, Serum-Free | 1 | 2011 | 45 | 0.020 |
Why?
|
Two-Hybrid System Techniques | 2 | 2001 | 50 | 0.020 |
Why?
|
ets-Domain Protein Elk-1 | 1 | 2011 | 28 | 0.020 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2011 | 26 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2016 | 807 | 0.020 |
Why?
|
Male | 1 | 2009 | 20025 | 0.020 |
Why?
|
Actins | 1 | 2011 | 148 | 0.020 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2006 | 17 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2006 | 61 | 0.020 |
Why?
|
Molecular Weight | 1 | 2006 | 167 | 0.020 |
Why?
|
Wound Healing | 1 | 2006 | 70 | 0.020 |
Why?
|
Embryo, Nonmammalian | 2 | 1996 | 59 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2006 | 269 | 0.020 |
Why?
|
Immunoblotting | 1 | 2003 | 176 | 0.010 |
Why?
|
Point Mutation | 1 | 2003 | 93 | 0.010 |
Why?
|
Models, Genetic | 1 | 2003 | 172 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2003 | 188 | 0.010 |
Why?
|
Epitopes | 1 | 2002 | 148 | 0.010 |
Why?
|
Ligands | 1 | 2003 | 349 | 0.010 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2002 | 289 | 0.010 |
Why?
|
Blotting, Northern | 1 | 2001 | 150 | 0.010 |
Why?
|
Biological Transport | 1 | 2000 | 185 | 0.010 |
Why?
|
Alleles | 1 | 2000 | 321 | 0.010 |
Why?
|
Glucose | 1 | 2000 | 230 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2001 | 893 | 0.010 |
Why?
|
Integrin alpha6beta1 | 1 | 1997 | 3 | 0.010 |
Why?
|
Platelet Glycoprotein GPIIb-IIIa Complex | 1 | 1997 | 3 | 0.010 |
Why?
|
Suppression, Genetic | 1 | 1997 | 6 | 0.010 |
Why?
|
Genetic Complementation Test | 1 | 1997 | 59 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 1997 | 502 | 0.010 |
Why?
|
Ectoderm | 1 | 1996 | 11 | 0.010 |
Why?
|
Female | 1 | 2014 | 20969 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 1996 | 515 | 0.010 |
Why?
|
Blastomeres | 1 | 1993 | 9 | 0.010 |
Why?
|
Extracellular Space | 1 | 1993 | 35 | 0.010 |
Why?
|
Alternative Splicing | 1 | 1993 | 85 | 0.010 |
Why?
|